1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic and clinical dataa
Pre-HD Controls Pre-HD Subjects HD Controls HD Patients (Stage I) Number of subjects 14 15 11 9 Age (yr) 31 ± 6.7 32 ± 6.6 49.7 ± 13.5 46.7 ± 8.5 Sex (M:F) 5:9 7:8 5:6 7:2 CAG repeats, expanded allele – 42.6 ± 3.1 – 45.1 ± 2.8 TFC score – 13 – 11.8 ± 1.4 Disease duration (yr) – – – 3.9 ± 3.6 UHDRS score – – – 17.3 ± 3.9
a Values are expressed as mean ± SD.